NatWest Group plc - ALEXION PHARMACEUTICALS INC ownership

ALEXION PHARMACEUTICALS INC's ticker is and the CUSIP is 15351109. A total of 16 filers reported holding ALEXION PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.4%.

Quarter-by-quarter ownership
NatWest Group plc ownership history of ALEXION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$819,000
+49.7%
4,725
+43.1%
0.01%
+120.0%
Q3 2014$547,000
-77.3%
3,302
-81.8%
0.01%
-91.8%
Q4 2013$2,405,000
+41.4%
18,099
+23.6%
0.06%
+24.5%
Q3 2013$1,701,000
-13.6%
14,643
-31.4%
0.05%
+75.0%
Q2 2013$1,969,00021,3420.03%
Other shareholders
ALEXION PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Ithaka Group 50,089$5,818,0001.35%
Redwood Investments, LLC 67,012$7,784,0001.10%
GARDNER LEWIS ASSET MANAGEMENT L P 30,557$3,550,0000.96%
TIAA CREF INVESTMENT MANAGEMENT LLC 3,187,985$370,316,0000.29%
Ohio National Investments, Inc. 7,525$874,0000.27%
SIT INVESTMENT ASSOCIATES INC 119,527$13,884,0000.27%
TEACHERS ADVISORS, LLC 826,396$95,994,0000.24%
ENDEX CAPITAL MANAGEMENT LLC 1,995$232,0000.24%
IBM Retirement Fund 80,963$9,404,0000.13%
FIRST NEW YORK SECURITIES LLC /NY 1,500$174,0000.07%
View complete list of ALEXION PHARMACEUTICALS INC shareholders